The Pharmaceutical Cannabis Report: 3rd Edition – Report (inc. Market Sizing Analysis), 2-Hour Analyst Consultation, Clinical Trials Database + Patent Portfolio
A digital copy of the report which includes an assessment of the market size of the pharmaceutical cannabis industry. This package includes a 2-hour consultation with one of Prohibition Partners’ senior analysts. This consultation can cover key findings of the report and additional insight. This is a bespoke consultation and can be tailored to your needs. Additionally, this packages includes a comprehensive list of clinical trials involving cannabis and cannabinoids taking place since 2010. The total number of clinical trials contained in the dataset is 440, as well as a comprehensive review of the patent portfolios of Jazz Pharmaceuticals Ltd. (split into those held by GW Research Ltd., and those held by GW Pharmaceuticals Ltd.), and of six other leading companies involved in patenting activity for the medical application of cannabis and cannabinoids. The dataset consists of unique patent families or “novel inventions” – meaning the same patent filed in multiple locations or at different times.